Literature DB >> 16179223

The del(2)(q32.2q33) deletion syndrome defined by clinical and molecular characterization of four patients.

G Van Buggenhout1, C Van Ravenswaaij-Arts, N Mc Maas, R Thoelen, A Vogels, Dominique Smeets, I Salden, G Matthijs, J-P Fryns, J R Vermeesch.   

Abstract

We report four patients with an interstitial deletion of chromosome 2q32-->2q33. They presented similar clinical findings including pre- and postnatal growth retardation, distinct facial dysmorphism, thin and sparse hair and fair built, micrognathia, cleft or high palate, relative macroglossia, dacrocystitis, persisting feeding difficulties, inguinal hernia and broad based gait. All were severely mentally retarded. Three patients had a specific behavioral phenotype with hyperactivity and motor restlessness, chaotic behavior, happy-personality but with periods of aggression and anxiety, sleeping problems and self-mutilation. (head-banging). Array CGH and fluorescence in situ hybridization (FISH) allowed us to delineate the deletion size and showed that the four patients share a 8.1 Mb minimal deleted region. Reviewing additional nine case reports of patients with similar deletions showed striking phenotypic similarities which enabled the delineation of the 2q32.2q33 syndrome. Deletion of 2q32 has been also associated with the wrinkly skin syndrome (WWS) and isolated cleft palate. Although the patients presented here shared many aspects of WWS, they did not had the wrinkly skin. All patients had a cleft or high palate, most likely as a result of hemizygosity for SATB2. A potential commonly deleted interval of the three patients with behavioral problems, excluding the deletion in the patient without behavioral problems, is at most 0.5 Mb in size harboring only two genes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16179223     DOI: 10.1016/j.ejmg.2005.05.005

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  29 in total

1.  Developmental microRNA expression profiling of murine embryonic orofacial tissue.

Authors:  Partha Mukhopadhyay; Guy Brock; Vasyl Pihur; Cynthia Webb; M Michele Pisano; Robert M Greene
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-07

2.  Autistic and dysmorphic features associated with a submicroscopic 2q33.3-q34 interstitial deletion detected by array comparative genomic hybridization.

Authors:  Duane T Brandau; Molly Lund; Linda D Cooley; Warren G Sanger; Merlin G Butler
Journal:  Am J Med Genet A       Date:  2008-02-15       Impact factor: 2.802

3.  Genomic alterations in biliary atresia suggest region of potential disease susceptibility in 2q37.3.

Authors:  Melissa Leyva-Vega; Jennifer Gerfen; Brian D Thiel; Dorota Jurkiewicz; Elizabeth B Rand; Joanna Pawlowska; Diana Kaminska; Pierre Russo; Xiaowu Gai; Ian D Krantz; Binita M Kamath; Hakon Hakonarson; Barbara A Haber; Nancy B Spinner
Journal:  Am J Med Genet A       Date:  2010-04       Impact factor: 2.802

4.  Genomic Investigation of Balanced Chromosomal Rearrangements in Patients with Abnormal Phenotypes.

Authors:  Milena Simioni; François Artiguenave; Vincent Meyer; Ilária C Sgardioli; Nilma L Viguetti-Campos; Isabella Lopes Monlleó; Andréa T Maciel-Guerra; Carlos E Steiner; Vera L Gil-da-Silva-Lopes
Journal:  Mol Syndromol       Date:  2017-06-01

5.  A novel deletion in 2q24.1q24.2 in a girl with mental retardation and generalized hypotonia: a case report.

Authors:  Orazio Palumbo; Pietro Palumbo; Teresa Palladino; Raffaella Stallone; Leopoldo Zelante; Massimo Carella
Journal:  Mol Cytogenet       Date:  2012-01-03       Impact factor: 2.009

Review 6.  What's new in karyotyping? The move towards array comparative genomic hybridisation (CGH).

Authors:  Thomy J L de Ravel; Koen Devriendt; Jean-Pierre Fryns; Joris R Vermeesch
Journal:  Eur J Pediatr       Date:  2007-03-20       Impact factor: 3.183

Review 7.  Role of titin in cardiomyopathy: from DNA variants to patient stratification.

Authors:  James S Ware; Stuart A Cook
Journal:  Nat Rev Cardiol       Date:  2017-12-14       Impact factor: 32.419

8.  A cross-species analysis of Satb2 expression suggests deep conservation across vertebrate lineages.

Authors:  Kelly Sheehan-Rooney; Božena Pálinkášová; Johann K Eberhart; Michael J Dixon
Journal:  Dev Dyn       Date:  2010-12       Impact factor: 3.780

9.  Small deletions of SATB2 cause some of the clinical features of the 2q33.1 microdeletion syndrome.

Authors:  Jill A Rosenfeld; Blake C Ballif; Ann Lucas; Edward J Spence; Cynthia Powell; Arthur S Aylsworth; Beth A Torchia; Lisa G Shaffer
Journal:  PLoS One       Date:  2009-08-10       Impact factor: 3.240

10.  Disorders with similar clinical phenotypes reveal underlying genetic interaction: SATB2 acts as an activator of the UPF3B gene.

Authors:  Petcharat Leoyklang; Kanya Suphapeetiporn; Chalurmpon Srichomthong; Siraprapa Tongkobpetch; Stefanie Fietze; Heidi Dorward; Andrew R Cullinane; William A Gahl; Marjan Huizing; Vorasuk Shotelersuk
Journal:  Hum Genet       Date:  2013-08-08       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.